Maximize the chance of success: Zhongshan Business Oppurtunities Promotion Seminar

Date: December 15, 2017 @ 5:00 pm – @ 8:00 pm
Location: Junior Ballroom on 2nd Floor at Marriott Oakland City Center, 1001 Broadway, Oakland, CA

Supporting Pillars, Success Story & Funding Opportunities by Zhongshan Municipal Gov’t 

Please note: dinner may not be available if the registration is after 10pm on Dec. 14.

Zhongshan Municipal People’s Government will host “Zhongshan Investment Opportunities Promotion Seminar” on Dec 15, 5:00pm-8:00pm, at Junior Ballroom of Marriott Oakland City Center. We cordially invite you and your colleagues to attend this event.

Besides Mayor of Zhongshan and the delegates, the event will also attract other local officials including California State Officials, Alameda County Officials, Mayor of Oakland, city council members and a lot of representatives of biotech/pharma companies.

Zhongshan is the hometown of Dr. Sun Yat-sen, the great forerunner of China’s democratic revolution. In 2016, the city’s per capita GDP reached $15,000; the total size of R&D investment topped USD ~$1 billion with 7,597 filed patent applications, accounting for 2.4% of the total GDP.  In addition, there are 882 high-tech enterprises and 42 post-Ph.D work stations. It also nested over 160 universities and research institutions.  The National Health Technology Park in Zhongshan is one of the first national health industrial park in China, which had generated about $6 Billion USD output in 2016.  Besides Novartis Group, Ferring, A&Z and other globally well-known pharmaceutical companies, it is also the home for hundreds of biotech/pharma and medical devices companies.

The success of Akeso Bio Pharma is considered a natural outcome from the park incubator program.  The company focuses on discovering and developing innovative biologics with international intellectual rights for the treatment of a broad spectrum of diseases, especially in co-developing antibody drugs with strategic partners.  Following its A-round seeding investment in July 2015, it soon secured the collaboration with Merck for R&D and commercialization of an immune checkpoint blocking antibody AK107, which lead to as much as $200M USD milestone payment.

We sincerely invite you to attend this limited-seat event, where you could have opportunity to meet and talk with the government officials as well as other associates.  The tentative agenda is listed below for your reference.

  • ·      17:00 – 17:30 Registration
  • ·      17:30 – 17:50 Keynote speech
  • ·      17:50 – 18:10 Presentation on Zhongshan investment opportunities
  • ·      18:10 – 18:30 Success story sharing
  • ·      18:30 Dinner & Networking

中山市人民政府将于2017年12月15日 在美国加州奥克兰市万豪酒店举行的“中山市投资环境推介会”, 诚挚邀请各位嘉宾出席，会后晚餐和自由交流。

出席此次活动的主要人员有中山市市长及随行代表团、加州州立政府官员、Alameda县政府官员、奥克兰市长、市议员及生物制药领域其他同行们。

中山市是中国民主革命的伟大先行者孙中山的故乡。2016年全市人均国民生产总值达到$15,000 元，研发投入总额达$10亿美元,申请专利7597项,占全市国内生产总值的2.4%。另外市内还有882家高新技术企业，42家博士后工作站，160多所大学和研究机构。中山市国家健康科技园是第一批国家级健康产业园，2016年全年产值约为60亿美元。除了诺华集团、辉凌制药、安士制药等全球知名制药企业，也有数百家的生物/制药和医疗设备公司入住 。

康方生物是一家总部设立在广东省中山市火炬开发区国家健康产业基地的创新型生物制药公司，也是从园区孵化器项目中走出的一个成功案例。公司成立于2012年3月。在2015年7月成功完成A轮融资后，于2015年11月，与默沙东就一项肿瘤免疫疗法的单克隆抗体药物AK107的研究、开发和推广达成合作，并得到以总价为2亿美元的里程碑形式的款项。AK-107是由康方生物在中国发现、用于肿瘤免疫治疗的免疫检查点阻断抗体。康方生物将分享他们在中山市发展的成功经验。

我们诚挚邀请您注册参加此次活动。名额有限，报名从速！下面是此次活动议程供您参考。

  • ·      17:00 – 17:30 注册
  • ·      17:30 – 17:50 主要领导发言
  • ·      17:50 – 18:10 中山投资环境介绍
  • ·      18:10 – 18:30 康方生物公司介绍成功经验
  • ·      18:30 – 晚餐及交流

everyone – $0 (USD)